- Home
- NRSN vs AEON Comparison
NRSN vs AEON Comparison
Compare NRSN & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRSN | AEON |
|---|---|---|
| Founded | 2017 | N/A |
| Country | Israel | United States |
| Employees | 15 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9M | 25.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRSN | AEON |
|---|---|---|
| Price | $0.87 | $1.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $7.20 |
| AVG Volume (30 Days) | ★ 160.7K | 90.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.68 | $0.38 |
| 52 Week High | $2.60 | $1.45 |
Technical Indicators
Market Signals| Indicator | NRSN | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 40.18 | 55.39 |
| Support Level | $0.68 | $0.67 |
| Resistance Level | $1.30 | $1.41 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 7.26 | 51.74 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.